Severe COVID-19 in pregnancy was associated with higher risks of adverse maternal, and neonatal outcomes. Disclosure of Interest: None DeclaredBerard, A.Sheehy, O.Kaul, P.Eltonsy, S.Walker, M.Hawken, S.Bernatsky, S.Pugliese, M.Barrett, O....
This cohort study evaluates the risks of neonatal adverse events after exposure to COVID-19 vaccination during pregnancy.
eTable 10.Sensitivity analysis stratifying by second and third vaccine dose in pregnancy eFigure 1.Distributions by maternal vaccination status eFigure 2.Cumulative proportion of infants with a positive SARS-CoV-2 test by maternal vaccination and infant age ...
evidence on susceptibility to SARS-CoV-2 infection in pregnancy is still limited. The aim of the study is to compare the likelihood of undergoing a SARS-CoV-2 test and testing positive for COVID-19 in pregnancy and puerperium with that of the general female population of reproductive age. ...
PE diagnosis were identified by ICD-10 code I26. Considering that most COVID-19 patients had their first stay in the emergency department or short term COVID-19 unit, we considered that PE was present on admission if it was diagnosed in the first hospital unit of stay. We also created ...
9, 10, 11 Despite the widely known risks of severe illness and death from COVID-19 in pregnancy, women of reproductive age still experience vaccine hesitancy, especially those from minority ethnic groups.12 National surveillance data show approximately a quarter of women in England of reproductive...
Studies have indicated that COVID-19 infection may accelerate the aging process in organisms. However, it remains unknown whether contracting COVID-19 affects life expectancy. Furthermore, the underlying biological mechanisms behind these findings are st
In addition, the impact of multimorbidity, and health conditions were explored in separate models to prevent issues with collinearity. Sub-analyses were conducted to characterise incomplete vaccine schedule in pregnancy. Analyses were restricted to women aged 18–55 years at the time of their first ...
This cohort study examines the association between maternal immunization with the BNT162b2 COVID-19 vaccine during pregnancy and neonatal and early infant
Eligibility criteria in the COVID-19 cohorts included: (1) patients who had an initial COVID-19 ICD-10-CM diagnosis code U07.1 or positive SARS-CoV-2 nucleic acid test result (eTable 1 in the Supplement) recorded in the hospital between April 1, 2020, and May 31, 2021, (2) patients...